Shuttle Pharmaceuticals Inc

SHPH

Latest QuantConomy context for SHPH: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for SHPH. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for SHPH

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
corporate event reg fd disclosure	neutral	75	Jul 1, 10:05 AM	SHPH filed 8-K: Regulation FD Disclosure, Other Events - 2 material events - [strong neutral signal]
fundamental eps change	very bullish	76	May 15, 12:00 AM	SHPH (Q1 2026, diluted eps): EPS grew 94.0% ($-7.16 → $-0.43). [sequential period basis, very bullish signal]
fundamental operating income change	very bullish	76	May 15, 12:00 AM	SHPH (Q1 2026, operating income): grew 81.4% (-$11.92M → -$2.22M). [sequential period basis, very bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
SHPH	NASDAQ	alphavantage	Shuttle Pharmaceuticals Holdings Inc
SHPH	NASDAQ	fmp	Shuttle Pharmaceuticals Holdings, Inc.

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Jul 7, 2026	HRT FINANCIAL LP	Insider	sale	10,580	$3.33	$35,231	4 on EDGAR
Jul 2, 2026	HRT FINANCIAL LP	Insider	purchase	7,851	$3.54	$27,793	4 on EDGAR
—	HRT FINANCIAL LP	Insider	—	—	—	—	3 on EDGAR
Jun 29, 2026	HRT FINANCIAL LP	Insider	purchase	25,836	$3.44	$88,876	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.